Thomas Sejersen

Thomas Sejersen is a Professor and Senior Physician at Karolinska Institutet, affiliated with the Division of Paediatric Neurology within the Department of Women's and Children's Health. His email is thomas.sejersen@ki.se, and he is based in Stockholm. His research focuses on neuromuscular disorders, particularly spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD), and myotonic dystrophy. He has contributed to clinical trials, gene therapy development, and healthcare economics analysis for rare diseases.

Research Interests:

• Molecular mechanisms of neuromuscular diseases
• Clinical management and quality of life in SMA and DMD patients
• Gene therapy and disease-modifying treatments
• Clinical epidemiology and healthcare resource utilization

Recent Work Trends: Recent publications emphasize consensus guidelines for transitioning DMD patients to adult care, cost analyses of SMA therapies, and molecular studies on autophagy and mitochondrial dysfunction in muscle cells. He also collaborates internationally on genomic studies for rare neuromuscular disorders.

Grants & Advising: While specific grants aren't listed, his research indicates involvement in multi-national studies and clinical trials. He advises on treatment protocols and serves on editorial boards.

Labs/Teams: Active in collaborative networks focused on paediatric neurology and rare disease research at Karolinska Institutet.